Basic Study on transplantation of Langerhans islets into the liver via hepatic artery in animals.
朗格汉斯胰岛经肝动脉移植入动物肝脏的基础研究。
基本信息
- 批准号:02670591
- 负责人:
- 金额:$ 1.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1990
- 资助国家:日本
- 起止时间:1990 至 1991
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
At the beginning of the experiment, an experimental model was prepared by adult hybrid dogs but liberation of pancreatic cells of dogs was difficult making it impossible to continue the experiment. Therefore, the experimental animals were changed from hybrid dogs to SD strain male rats. Pancreatic cells of rats were relatively easily liberated and many free cells were able to be recovered. However, the hepatic artery of a rat was too fine to permit planned infusion of free pancreatic cells and therefore it took time to establish the technique. Free pancreatic colls were successfully infused into the liver by infusing them into the gastroduodenal artery after cramping the common hepatic artery and gastroduodenal artery. It was also successful to visually confirm the pancreatic cells had survived. The confirm this, diabetic rats were used. Diabetic rats were prepared by intravenous injection of streptozotocin.It will be necessary, after this, to confirm the survival of transplanted pancreatic cells using diabetic rats.Besides that, the end to side anastomosis of the portal vein and inferior vena cava and transposition of the portal vein and inferior vena cava were also successful in an animal model.After this, it will be necessary to transplant free pancreatic cells into the liver via the hepatic artery using the planned animal model (end to side anastomosis of the portal vein and inferior vena cava and transposition of the portal vein and inferior vena cava) in order to demonstrate the effect of the hepatotrophic factor secreted from pancreatic cells as a regenerative factor of the liver.
在实验开始时,用成年杂种狗制备实验模型,但狗的胰腺细胞的释放很困难,使得不可能继续实验。因此,将实验动物由杂种犬变更为SD系雄性大鼠。大鼠胰腺细胞相对容易释放,并且能够回收许多游离细胞。然而,大鼠的肝动脉太细,不允许有计划地输注游离胰腺细胞,因此建立该技术需要时间。在夹闭肝总动脉和胃十二指肠动脉后,通过将游离胰结肠注入胃十二指肠动脉成功地将游离胰结肠注入肝脏。还成功地目视确认了胰腺细胞存活。为了证实这一点,使用了糖尿病大鼠。通过静脉注射链脲佐菌素制备糖尿病大鼠。之后,需要确认使用糖尿病大鼠移植的胰腺细胞的存活。此外,门静脉和下腔静脉的端侧吻合和门静脉和下腔静脉的移位在动物模型中也是成功的。之后,必须使用计划的动物模型通过肝动脉将游离胰腺细胞移植到肝脏中(门静脉-下腔静脉端侧吻合术和门静脉-下腔静脉转位术)以证明从胰腺细胞分泌的肝营养因子作为肝再生因子的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KOBAYASHI Susumu其他文献
KOBAYASHI Susumu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KOBAYASHI Susumu', 18)}}的其他基金
Development and Application of Highly Stereoselective Aldol Reactions Using Chiral Amide
手性酰胺高立体选择性羟醛反应的开发与应用
- 批准号:
22390004 - 财政年份:2010
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Synthetic Investigation of Biologically Active Natural Products Based on the Development of Highly Stereoselective Reaction
基于高度立体选择性反应的生物活性天然产物的合成研究
- 批准号:
18390010 - 财政年份:2006
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Synthetic Investigation on the Structure-Function of Biologically Significant Marine Natural Products
具有生物学意义的海洋天然产物的结构功能综合研究
- 批准号:
13470473 - 财政年份:2001
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a Potent Inhibitor of Metastasis Based on a Cyclic Lysophosphatidic Acid
基于环状溶血磷脂酸的有效转移抑制剂的开发
- 批准号:
13557212 - 财政年份:2001
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
DPC4/Smad4 Expression Adenovirus Vector for Pancreas Cancer Therapy
用于胰腺癌治疗的 DPC4/Smad4 表达腺病毒载体
- 批准号:
12671202 - 财政年份:2000
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
p16 Expression Adenovirus Vector for Esophageal and Pancreas Cancer Therapy.
用于食管癌和胰腺癌治疗的 p16 表达腺病毒载体。
- 批准号:
09671280 - 财政年份:1997
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Formation mechanism of the reflected shock wave over curved surfaces.
曲面反射冲击波的形成机制。
- 批准号:
08650220 - 财政年份:1996
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CANCER CONTROL TRIAL BY C-MYC ANTISENSE DNA
C-MYC 反义 DNA 的癌症控制试验
- 批准号:
06671243 - 财政年份:1994
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Catalytic Enantioselective Reaction
催化对映选择性反应
- 批准号:
01470137 - 财政年份:1989
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Impaired islet hormone secretion by CD36, a new pathophysiology of type 2 diabetes : Validation in human pancreatic islets
CD36 导致的胰岛激素分泌受损,这是 2 型糖尿病的新病理生理学:在人胰岛中的验证
- 批准号:
22KK0281 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Specific senescence detection in pancreatic islets
胰岛的特异性衰老检测
- 批准号:
10648322 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
The Antigen Repertoire of CD4 T cells from Pancreatic Islets
胰岛 CD4 T 细胞的抗原库
- 批准号:
10503562 - 财政年份:2022
- 资助金额:
$ 1.28万 - 项目类别:
Role of cytochrome P450 enzymes in pancreatic islets and diabetes pathophysiology
细胞色素 P450 酶在胰岛和糖尿病病理生理学中的作用
- 批准号:
572785-2022 - 财政年份:2022
- 资助金额:
$ 1.28万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Biomimetic Materials and Bioprocesses for High-Density Cultures of Pancreatic Islets and Tissues
用于胰岛和组织高密度培养的仿生材料和生物过程
- 批准号:
RGPIN-2018-06131 - 财政年份:2022
- 资助金额:
$ 1.28万 - 项目类别:
Discovery Grants Program - Individual
The Antigen Repertoire of CD4 T cells from Pancreatic Islets
胰岛 CD4 T 细胞的抗原库
- 批准号:
10700133 - 财政年份:2022
- 资助金额:
$ 1.28万 - 项目类别:
Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion
人类胰岛的基因组编辑以抵抗缺血性损伤并促进免疫逃避
- 批准号:
10657743 - 财政年份:2022
- 资助金额:
$ 1.28万 - 项目类别:
Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion
人类胰岛的基因组编辑以抵抗缺血性损伤并促进免疫逃避
- 批准号:
10504937 - 财政年份:2022
- 资助金额:
$ 1.28万 - 项目类别:
Understanding the hepatic microenvironment to improve function and survival of transplanted pancreatic islets in diabetes
了解肝脏微环境以改善糖尿病患者移植胰岛的功能和存活率
- 批准号:
MR/X00211X/1 - 财政年份:2022
- 资助金额:
$ 1.28万 - 项目类别:
Fellowship